Smith & Nephew Inc (NYSE: SNN) (LSE: SN) Advanced Wound Management division, announces the U.S. launch of ACTICOAT™ Flex 3 and ACTICOAT™ Flex 7. According to the company, ACTICOAT Flex products have been designed to support physicians dealing with wounds and injuries at high risk of infection. Features include:
- Use of the unique Silcryst® nanocrystalline silver technology of ACTICOAT to provide conformability on awkward anatomical areas such as face and hands.
- Stretch properties to improve patient comfort during wear.
- Recent FDA-clearance for market.
For more information, visit our Web www.smith-nephew.com